ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa03010	Ribosome	9/121	158/8135	0.0005533	0.1018	0.1018	RPL37/RPS13/RPL7/RPS21/RPS18/RPS27/RPS3A/RPL12/MRPL13	9
KEGG	hsa05171	Coronavirus disease - COVID-19	10/121	232/8135	0.002328	0.2142	0.2142	RPL37/IKBKE/CCL2/RPS13/RPL7/RPS21/RPS18/RPS27/RPS3A/RPL12	10
KEGG	hsa04657	IL-17 signaling pathway	5/121	94/8135	0.01285	0.6432	0.6432	S100A8/IKBKE/CCL2/CEBPB/MUC5AC	5
KEGG	hsa05150	Staphylococcus aureus infection	5/121	96/8135	0.01398	0.6432	0.6432	DEFA3/KRT20/KRT35/KRT27/DEFA1	5
KEGG	hsa04080	Neuroactive ligand-receptor interaction	10/121	353/8135	0.03708	0.9872	0.9872	LPAR1/HTR2C/GABRR1/MC2R/RLN2/ADRA1A/CTSG/GRM4/TRHR/GABRG2	10
KEGG	hsa04350	TGF-beta signaling pathway	4/121	94/8135	0.05112	0.9872	0.9872	PITX2/BMP5/LTBP1/ACVR2B	4
KEGG	hsa00650	Butanoate metabolism	2/121	28/8135	0.06452	0.9872	0.9872	ABAT/HADHA	2
KEGG	hsa03013	Nucleocytoplasmic transport	4/121	108/8135	0.07695	0.9872	0.9872	UBE2I/NXF2/EEF1A1/SNUPN	4
KEGG	hsa00410	beta-Alanine metabolism	2/121	31/8135	0.07715	0.9872	0.9872	ABAT/HADHA	2
KEGG	hsa00640	Propanoate metabolism	2/121	32/8135	0.08152	0.9872	0.9872	ABAT/HADHA	2
KEGG	hsa03030	DNA replication	2/121	36/8135	0.0997	0.9872	0.9872	RFC2/DNA2	2
KEGG	hsa05033	Nicotine addiction	2/121	40/8135	0.1189	0.9872	0.9872	GABRR1/GABRG2	2
KEGG	hsa04146	Peroxisome	3/121	82/8135	0.1226	0.9872	0.9872	PEX5/DHRS4/PEX11G	3
KEGG	hsa04727	GABAergic synapse	3/121	89/8135	0.1463	0.9872	0.9872	ABAT/GABRR1/GABRG2	3
KEGG	hsa04020	Calcium signaling pathway	6/121	240/8135	0.1473	0.9872	0.9872	CASQ1/HTR2C/FLT1/ADRA1A/NGF/TRHR	6
KEGG	hsa04060	Cytokine-cytokine receptor interaction	7/121	295/8135	0.1496	0.9872	0.9872	BMP5/CCL2/NGF/ACVR2B/IL12RB2/TNFRSF6B/IL27RA	7
KEGG	hsa00280	Valine, leucine and isoleucine degradation	2/121	48/8135	0.1596	0.9872	0.9872	ABAT/HADHA	2
KEGG	hsa05323	Rheumatoid arthritis	3/121	93/8135	0.1605	0.9872	0.9872	FLT1/CCL2/ATP6V1B1	3
KEGG	hsa00520	Amino sugar and nucleotide sugar metabolism	2/121	49/8135	0.1649	0.9872	0.9872	FPGT/GNPDA1	2
KEGG	hsa04810	Regulation of actin cytoskeleton	5/121	218/8135	0.2241	0.9872	0.9872	LPAR1/MYLPF/ITGB3/ACTR3B/WASL	5
KEGG	hsa00511	Other glycan degradation	1/121	18/8135	0.2366	0.9872	0.9872	FUCA2	1
KEGG	hsa04623	Cytosolic DNA-sensing pathway	2/121	63/8135	0.2408	0.9872	0.9872	IKBKE/POLR3B	2
KEGG	hsa05164	Influenza A	4/121	171/8135	0.2499	0.9872	0.9872	IKBKE/CCL2/NXF2/CPSF4	4
KEGG	hsa04919	Thyroid hormone signaling pathway	3/121	121/8135	0.2685	0.9872	0.9872	ITGB3/RCAN2/MED13	3
KEGG	hsa00900	Terpenoid backbone biosynthesis	1/121	22/8135	0.2812	0.9872	0.9872	GGPS1	1
KEGG	hsa03430	Mismatch repair	1/121	23/8135	0.2919	0.9872	0.9872	RFC2	1
KEGG	hsa04614	Renin-angiotensin system	1/121	23/8135	0.2919	0.9872	0.9872	CTSG	1
KEGG	hsa04621	NOD-like receptor signaling pathway	4/121	184/8135	0.2929	0.9872	0.9872	DEFA3/IKBKE/CCL2/DEFA1	4
KEGG	hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	1/121	24/8135	0.3024	0.9872	0.9872	EXT2	1
KEGG	hsa05168	Herpes simplex virus 1 infection	9/121	495/8135	0.3157	0.9872	0.9872	ZNF81/IKBKE/CCL2/ITGB3/NXF2/ZNF765/ZNF605/ZNF707/ZNF441	9
KEGG	hsa05100	Bacterial invasion of epithelial cells	2/121	77/8135	0.3181	0.9872	0.9872	ACTR3B/WASL	2
KEGG	hsa05202	Transcriptional misregulation in cancer	4/121	193/8135	0.3232	0.9872	0.9872	DEFA3/FLT1/CEBPB/DEFA1	4
KEGG	hsa04721	Synaptic vesicle cycle	2/121	78/8135	0.3236	0.9872	0.9872	SLC18A2/ATP6V1B1	2
KEGG	hsa00062	Fatty acid elongation	1/121	27/8135	0.3332	0.9872	0.9872	HADHA	1
KEGG	hsa04966	Collecting duct acid secretion	1/121	27/8135	0.3332	0.9872	0.9872	ATP6V1B1	1
KEGG	hsa05135	Yersinia infection	3/121	137/8135	0.3337	0.9872	0.9872	CCL2/ACTR3B/WASL	3
KEGG	hsa04915	Estrogen signaling pathway	3/121	138/8135	0.3377	0.9872	0.9872	KRT20/KRT35/KRT27	3
KEGG	hsa05418	Fluid shear stress and atherosclerosis	3/121	139/8135	0.3418	0.9872	0.9872	CCL2/ITGB3/ACVR2B	3
KEGG	hsa04392	Hippo signaling pathway - multiple species	1/121	29/8135	0.353	0.9872	0.9872	FAT4	1
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	3/121	143/8135	0.3582	0.9872	0.9872	DUSP9/HAND1/ACVR2B	3
KEGG	hsa04742	Taste transduction	2/121	86/8135	0.367	0.9872	0.9872	GRM4/TAS2R9	2
KEGG	hsa04710	Circadian rhythm	1/121	31/8135	0.3721	0.9872	0.9872	FBXW11	1
KEGG	hsa04540	Gap junction	2/121	88/8135	0.3777	0.9872	0.9872	LPAR1/HTR2C	2
KEGG	hsa04015	Rap1 signaling pathway	4/121	210/8135	0.3809	0.9872	0.9872	LPAR1/FLT1/ITGB3/NGF	4
KEGG	hsa00051	Fructose and mannose metabolism	1/121	33/8135	0.3907	0.9872	0.9872	FPGT	1
KEGG	hsa05032	Morphine addiction	2/121	91/8135	0.3936	0.9872	0.9872	GABRR1/GABRG2	2
KEGG	hsa03020	RNA polymerase	1/121	34/8135	0.3998	0.9872	0.9872	POLR3B	1
KEGG	hsa00350	Tyrosine metabolism	1/121	36/8135	0.4176	0.9872	0.9872	DCT	1
KEGG	hsa00512	Mucin type O-glycan biosynthesis	1/121	36/8135	0.4176	0.9872	0.9872	GALNT8	1
KEGG	hsa03015	mRNA surveillance pathway	2/121	97/8135	0.4249	0.9872	0.9872	NXF2/CPSF4	2
KEGG	hsa00250	Alanine, aspartate and glutamate metabolism	1/121	37/8135	0.4263	0.9872	0.9872	ABAT	1
KEGG	hsa01250	Biosynthesis of nucleotide sugars	1/121	37/8135	0.4263	0.9872	0.9872	FPGT	1
KEGG	hsa04750	Inflammatory mediator regulation of TRP channels	2/121	98/8135	0.43	0.9872	0.9872	HTR2C/NGF	2
KEGG	hsa03440	Homologous recombination	1/121	41/8135	0.4599	0.9872	0.9872	TOPBP1	1
KEGG	hsa04064	NF-kappa B signaling pathway	2/121	104/8135	0.4602	0.9872	0.9872	CARD14/UBE2I	2
KEGG	hsa00380	Tryptophan metabolism	1/121	42/8135	0.4679	0.9872	0.9872	HADHA	1
KEGG	hsa00071	Fatty acid degradation	1/121	43/8135	0.4759	0.9872	0.9872	HADHA	1
KEGG	hsa04931	Insulin resistance	2/121	108/8135	0.4799	0.9872	0.9872	MLXIPL/PPP1R3B	2
KEGG	hsa03008	Ribosome biogenesis in eukaryotes	2/121	109/8135	0.4847	0.9872	0.9872	FCF1/NXF2	2
KEGG	hsa03022	Basal transcription factors	1/121	45/8135	0.4915	0.9872	0.9872	GTF2A1	1
KEGG	hsa03050	Proteasome	1/121	46/8135	0.4991	0.9872	0.9872	PSME3	1
KEGG	hsa04668	TNF signaling pathway	2/121	112/8135	0.4991	0.9872	0.9872	CCL2/CEBPB	2
KEGG	hsa05131	Shigellosis	4/121	247/8135	0.5036	0.9872	0.9872	MYLPF/ACTR3B/WASL/FBXW11	4
KEGG	hsa00514	Other types of O-glycan biosynthesis	1/121	47/8135	0.5066	0.9872	0.9872	GALNT8	1
KEGG	hsa03420	Nucleotide excision repair	1/121	47/8135	0.5066	0.9872	0.9872	RFC2	1
KEGG	hsa04724	Glutamatergic synapse	2/121	114/8135	0.5085	0.9872	0.9872	SHANK2/GRM4	2
KEGG	hsa04726	Serotonergic synapse	2/121	115/8135	0.5132	0.9872	0.9872	HTR2C/SLC18A2	2
KEGG	hsa05030	Cocaine addiction	1/121	49/8135	0.5212	0.9872	0.9872	SLC18A2	1
KEGG	hsa00510	N-Glycan biosynthesis	1/121	50/8135	0.5284	0.9872	0.9872	MGAT3	1
KEGG	hsa04979	Cholesterol metabolism	1/121	50/8135	0.5284	0.9872	0.9872	LPA	1
KEGG	hsa05110	Vibrio cholerae infection	1/121	50/8135	0.5284	0.9872	0.9872	ATP6V1B1	1
KEGG	hsa05144	Malaria	1/121	50/8135	0.5284	0.9872	0.9872	CCL2	1
KEGG	hsa03460	Fanconi anemia pathway	1/121	54/8135	0.556	0.9872	0.9872	FANCG	1
KEGG	hsa05130	Pathogenic Escherichia coli infection	3/121	197/8135	0.5652	0.9872	0.9872	LPAR1/ACTR3B/WASL	3
KEGG	hsa04340	Hedgehog signaling pathway	1/121	56/8135	0.5692	0.9872	0.9872	FBXW11	1
KEGG	hsa01212	Fatty acid metabolism	1/121	57/8135	0.5756	0.9872	0.9872	HADHA	1
KEGG	hsa05134	Legionellosis	1/121	57/8135	0.5756	0.9872	0.9872	EEF1A1	1
KEGG	hsa04510	Focal adhesion	3/121	201/8135	0.5789	0.9872	0.9872	FLT1/MYLPF/ITGB3	3
KEGG	hsa04142	Lysosome	2/121	132/8135	0.5881	0.9872	0.9872	FUCA2/CTSG	2
KEGG	hsa00140	Steroid hormone biosynthesis	1/121	61/8135	0.6005	0.9872	0.9872	SULT1E1	1
KEGG	hsa00310	Lysine degradation	1/121	63/8135	0.6124	0.9872	0.9872	HADHA	1
KEGG	hsa03250	Viral life cycle - HIV-1	1/121	63/8135	0.6124	0.9872	0.9872	SERINC5	1
KEGG	hsa04927	Cortisol synthesis and secretion	1/121	65/8135	0.6239	0.9872	0.9872	MC2R	1
KEGG	hsa05321	Inflammatory bowel disease	1/121	65/8135	0.6239	0.9872	0.9872	IL12RB2	1
KEGG	hsa04120	Ubiquitin mediated proteolysis	2/121	142/8135	0.6281	0.9872	0.9872	UBE2I/FBXW11	2
KEGG	hsa00830	Retinol metabolism	1/121	68/8135	0.6406	0.9872	0.9872	DHRS4	1
KEGG	hsa04740	Olfactory transduction	6/121	440/8135	0.6452	0.9872	0.9872	OR8D1/OR51Q1/OR6N1/ANO2/OR12D3/OR13D1	6
KEGG	hsa05031	Amphetamine addiction	1/121	69/8135	0.646	0.9872	0.9872	SLC18A2	1
KEGG	hsa03040	Spliceosome	2/121	147/8135	0.6469	0.9872	0.9872	SNRPB2/SNRPE	2
KEGG	hsa04072	Phospholipase D signaling pathway	2/121	148/8135	0.6506	0.9872	0.9872	LPAR1/GRM4	2
KEGG	hsa04723	Retrograde endocannabinoid signaling	2/121	148/8135	0.6506	0.9872	0.9872	GABRR1/GABRG2	2
KEGG	hsa04622	RIG-I-like receptor signaling pathway	1/121	70/8135	0.6513	0.9872	0.9872	IKBKE	1
KEGG	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1/121	70/8135	0.6513	0.9872	0.9872	ATP6V1B1	1
KEGG	hsa04520	Adherens junction	1/121	71/8135	0.6565	0.9872	0.9872	WASL	1
KEGG	hsa04145	Phagosome	2/121	152/8135	0.665	0.9872	0.9872	ITGB3/ATP6V1B1	2
KEGG	hsa04115	p53 signaling pathway	1/121	73/8135	0.6668	0.9872	0.9872	CCNG1	1
KEGG	hsa04918	Thyroid hormone synthesis	1/121	75/8135	0.6767	0.9872	0.9872	ASGR2	1
KEGG	hsa04390	Hippo signaling pathway	2/121	157/8135	0.6824	0.9872	0.9872	BMP5/FBXW11	2
KEGG	hsa05160	Hepatitis C	2/121	157/8135	0.6824	0.9872	0.9872	IKBKE/PSME3	2
KEGG	hsa05140	Leishmaniasis	1/121	77/8135	0.6863	0.9872	0.9872	EEF1A1	1
KEGG	hsa05412	Arrhythmogenic right ventricular cardiomyopathy	1/121	77/8135	0.6863	0.9872	0.9872	ITGB3	1
KEGG	hsa00980	Metabolism of xenobiotics by cytochrome P450	1/121	78/8135	0.691	0.9872	0.9872	AKR7L	1
KEGG	hsa04612	Antigen processing and presentation	1/121	78/8135	0.691	0.9872	0.9872	PSME3	1
KEGG	hsa04630	JAK-STAT signaling pathway	2/121	162/8135	0.699	0.9872	0.9872	IL12RB2/IL27RA	2
KEGG	hsa04310	Wnt signaling pathway	2/121	167/8135	0.7149	0.9872	0.9872	INVS/FBXW11	2
KEGG	hsa04530	Tight junction	2/121	169/8135	0.721	0.9872	0.9872	MARVELD3/ACTR3B	2
KEGG	hsa05132	Salmonella infection	3/121	249/8135	0.7218	0.9872	0.9872	MYLPF/ACTR3B/WASL	3
KEGG	hsa04144	Endocytosis	3/121	251/8135	0.7268	0.9872	0.9872	ACTR3B/WASL/CHMP1A	3
KEGG	hsa04141	Protein processing in endoplasmic reticulum	2/121	171/8135	0.7271	0.9872	0.9872	UBXN4/BAG1	2
KEGG	hsa04512	ECM-receptor interaction	1/121	88/8135	0.7344	0.9872	0.9872	ITGB3	1
KEGG	hsa05410	Hypertrophic cardiomyopathy	1/121	90/8135	0.7424	0.9872	0.9872	ITGB3	1
KEGG	hsa04658	Th1 and Th2 cell differentiation	1/121	92/8135	0.7501	0.9872	0.9872	IL12RB2	1
KEGG	hsa04970	Salivary secretion	1/121	93/8135	0.7538	0.9872	0.9872	ADRA1A	1
KEGG	hsa04360	Axon guidance	2/121	182/8135	0.7584	0.9872	0.9872	EPHB4/EFNB3	2
KEGG	hsa05414	Dilated cardiomyopathy	1/121	96/8135	0.7648	0.9872	0.9872	ITGB3	1
KEGG	hsa04666	Fc gamma R-mediated phagocytosis	1/121	97/8135	0.7683	0.9872	0.9872	ACTR3B	1
KEGG	hsa04925	Aldosterone synthesis and secretion	1/121	98/8135	0.7718	0.9872	0.9872	MC2R	1
KEGG	hsa05231	Choline metabolism in cancer	1/121	98/8135	0.7718	0.9872	0.9872	SLC22A2	1
KEGG	hsa04640	Hematopoietic cell lineage	1/121	99/8135	0.7752	0.9872	0.9872	ITGB3	1
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	1/121	100/8135	0.7786	0.9872	0.9872	CCL2	1
KEGG	hsa04933	AGE-RAGE signaling pathway in diabetic complications	1/121	100/8135	0.7786	0.9872	0.9872	CCL2	1
KEGG	hsa04151	PI3K-Akt signaling pathway	4/121	354/8135	0.7787	0.9872	0.9872	LPAR1/FLT1/ITGB3/NGF	4
KEGG	hsa04613	Neutrophil extracellular trap formation	2/121	190/8135	0.7792	0.9872	0.9872	ITGB3/CTSG	2
KEGG	hsa04916	Melanogenesis	1/121	101/8135	0.7819	0.9872	0.9872	DCT	1
KEGG	hsa05142	Chagas disease	1/121	102/8135	0.7852	0.9872	0.9872	CCL2	1
KEGG	hsa05146	Amoebiasis	1/121	102/8135	0.7852	0.9872	0.9872	CTSG	1
KEGG	hsa04620	Toll-like receptor signaling pathway	1/121	104/8135	0.7917	0.9872	0.9872	IKBKE	1
KEGG	hsa04625	C-type lectin receptor signaling pathway	1/121	104/8135	0.7917	0.9872	0.9872	IKBKE	1
KEGG	hsa04922	Glucagon signaling pathway	1/121	107/8135	0.8009	0.9872	0.9872	SIK2	1
KEGG	hsa04659	Th17 cell differentiation	1/121	108/8135	0.8039	0.9872	0.9872	IL27RA	1
KEGG	hsa04066	HIF-1 signaling pathway	1/121	109/8135	0.8069	0.9872	0.9872	FLT1	1
KEGG	hsa04725	Cholinergic synapse	1/121	113/8135	0.8183	0.9872	0.9872	KCNJ14	1
KEGG	hsa04010	MAPK signaling pathway	3/121	294/8135	0.819	0.9872	0.9872	FLT1/DUSP9/NGF	3
KEGG	hsa04670	Leukocyte transendothelial migration	1/121	114/8135	0.821	0.9872	0.9872	MYLPF	1
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	2/121	212/8135	0.8286	0.9872	0.9872	IKBKE/PAQR5	2
KEGG	hsa04722	Neurotrophin signaling pathway	1/121	119/8135	0.8341	0.9872	0.9872	NGF	1
KEGG	hsa05417	Lipid and atherosclerosis	2/121	215/8135	0.8345	0.9872	0.9872	IKBKE/CCL2	2
KEGG	hsa04152	AMPK signaling pathway	1/121	120/8135	0.8366	0.9872	0.9872	ADRA1A	1
KEGG	hsa05206	MicroRNAs in cancer	3/121	310/8135	0.8459	0.9872	0.9872	UBE2I/ITGB3/CCNG1	3
KEGG	hsa04611	Platelet activation	1/121	124/8135	0.8463	0.9872	0.9872	ITGB3	1
KEGG	hsa04110	Cell cycle	1/121	126/8135	0.8509	0.9872	0.9872	STAG2	1
KEGG	hsa05163	Human cytomegalovirus infection	2/121	225/8135	0.8529	0.9872	0.9872	CCL2/ITGB3	2
KEGG	hsa00230	Purine metabolism	1/121	128/8135	0.8553	0.9872	0.9872	PDE6H	1
KEGG	hsa04380	Osteoclast differentiation	1/121	128/8135	0.8553	0.9872	0.9872	ITGB3	1
KEGG	hsa04926	Relaxin signaling pathway	1/121	129/8135	0.8575	0.9872	0.9872	RLN2	1
KEGG	hsa04114	Oocyte meiosis	1/121	131/8135	0.8618	0.9872	0.9872	FBXW11	1
KEGG	hsa04728	Dopaminergic synapse	1/121	132/8135	0.8639	0.9872	0.9872	SLC18A2	1
KEGG	hsa04014	Ras signaling pathway	2/121	232/8135	0.8646	0.9872	0.9872	FLT1/NGF	2
KEGG	hsa00190	Oxidative phosphorylation	1/121	134/8135	0.868	0.9872	0.9872	ATP6V1B1	1
KEGG	hsa04270	Vascular smooth muscle contraction	1/121	134/8135	0.868	0.9872	0.9872	ADRA1A	1
KEGG	hsa04210	Apoptosis	1/121	136/8135	0.8719	0.9872	0.9872	NGF	1
KEGG	hsa05322	Systemic lupus erythematosus	1/121	136/8135	0.8719	0.9872	0.9872	CTSG	1
KEGG	hsa04910	Insulin signaling pathway	1/121	137/8135	0.8739	0.9872	0.9872	PPP1R3B	1
KEGG	hsa05165	Human papillomavirus infection	3/121	331/8135	0.8759	0.9872	0.9872	IKBKE/ITGB3/ATP6V1B1	3
KEGG	hsa05162	Measles	1/121	139/8135	0.8777	0.9872	0.9872	IKBKE	1
KEGG	hsa04936	Alcoholic liver disease	1/121	142/8135	0.8831	0.9872	0.9872	IKBKE	1
KEGG	hsa05017	Spinocerebellar ataxia	1/121	143/8135	0.8849	0.9872	0.9872	SPTBN2	1
KEGG	hsa04514	Cell adhesion molecules	1/121	149/8135	0.895	0.9872	0.9872	NRCAM	1
KEGG	hsa05226	Gastric cancer	1/121	149/8135	0.895	0.9872	0.9872	REG4	1
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	1/121	150/8135	0.8966	0.9872	0.9872	ADRA1A	1
KEGG	hsa01240	Biosynthesis of cofactors	1/121	153/8135	0.9012	0.9872	0.9872	LIAS	1
KEGG	hsa04921	Oxytocin signaling pathway	1/121	154/8135	0.9027	0.9872	0.9872	KCNJ14	1
KEGG	hsa04932	Non-alcoholic fatty liver disease	1/121	155/8135	0.9042	0.9872	0.9872	MLXIPL	1
KEGG	hsa04934	Cushing syndrome	1/121	155/8135	0.9042	0.9872	0.9872	MC2R	1
KEGG	hsa04150	mTOR signaling pathway	1/121	156/8135	0.9056	0.9872	0.9872	ATP6V1B1	1
KEGG	hsa04218	Cellular senescence	1/121	156/8135	0.9056	0.9872	0.9872	FBXW11	1
KEGG	hsa04217	Necroptosis	1/121	159/8135	0.9099	0.9872	0.9872	CHMP1A	1
KEGG	hsa05012	Parkinson disease	2/121	266/8135	0.9105	0.9872	0.9872	SLC18A2/SLC39A13	2
KEGG	hsa05161	Hepatitis B	1/121	162/8135	0.9139	0.9872	0.9872	IKBKE	1
KEGG	hsa04022	cGMP-PKG signaling pathway	1/121	167/8135	0.9202	0.9872	0.9872	ADRA1A	1
KEGG	hsa05152	Tuberculosis	1/121	180/8135	0.9346	0.9872	0.9872	CEBPB	1
KEGG	hsa05034	Alcoholism	1/121	187/8135	0.9413	0.9872	0.9872	SLC18A2	1
KEGG	hsa04062	Chemokine signaling pathway	1/121	192/8135	0.9456	0.9872	0.9872	CCL2	1
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	1/121	194/8135	0.9473	0.9872	0.9872	IKBKE	1
KEGG	hsa05169	Epstein-Barr virus infection	1/121	202/8135	0.9534	0.9872	0.9872	IKBKE	1
KEGG	hsa05203	Viral carcinogenesis	1/121	204/8135	0.9548	0.9872	0.9872	GTF2A1	1
KEGG	hsa05205	Proteoglycans in cancer	1/121	205/8135	0.9555	0.9872	0.9872	ITGB3	1
KEGG	hsa05170	Human immunodeficiency virus 1 infection	1/121	212/8135	0.96	0.9872	0.9872	FBXW11	1
KEGG	hsa04024	cAMP signaling pathway	1/121	221/8135	0.9652	0.9872	0.9872	MC2R	1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	1/121	222/8135	0.9657	0.9872	0.9872	CRTC1	1
KEGG	hsa05014	Amyotrophic lateral sclerosis	2/121	364/8135	0.9745	0.9907	0.9907	DNAH2/NXF2	2
KEGG	hsa05016	Huntington disease	1/121	306/8135	0.9907	0.9972	0.9972	DNAH2	1
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	2/121	476/8135	0.9945	0.9972	0.9972	DNAH2/SPTBN2	2
KEGG	hsa05010	Alzheimer disease	1/121	384/8135	0.9972	0.9972	0.9972	SLC39A13	1